Translational Science Solutions helps medical device and digital health innovators navigate FDA challenges by bridging science, business, and regulatory affairs to drive smart strategy, seamless submissions, and accelerated market entry. They offer tailored regulatory services, including regulatory strategy development, FDA submission management, post-market support, and ongoing regulatory guidance across pathways such as 510(k), IDE, De Novo, and Breakthrough Device designations. Founded by Kathryn Becker in 2014 and based in Charleston, SC, the firm serves startups, established manufacturers, and academic researchers, turning innovative ideas into market-ready products.
AI named Translational Science Solutions in March 2026.